Immuneel Therapeutics welcomes Amit Mookim as CEO
Mookim will focus on establishing partnerships with providers, practitioners, and public health, and delivering current CART…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Immuneel Therapeutics
Immuneel to offer affordable cell and gene therapy for cancer patients in India
In this video, Arun Anand, COO, Immuneel Therapeutics and Dr Bruce Levine, of the University of Pennsylvania Perelman School of…
Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual…
Seventy seven overall responses at day 90 in patients with multi-line treated leukemia and lymphoma who received Varnimcabtagene…
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health…
The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias
Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy
Immuneel acquires exclusive license to CD19 CAR T product for the potential treatment of B cell malignancies for India